112 related articles for article (PubMed ID: 21459324)
21. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
22. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
[TBL] [Abstract][Full Text] [Related]
23. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
24. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue.
Rohm M; Sommerfeld A; Strzoda D; Jones A; Sijmonsma TP; Rudofsky G; Wolfrum C; Sticht C; Gretz N; Zeyda M; Leitner L; Nawroth PP; Stulnig TM; Berriel Diaz M; Vegiopoulos A; Herzig S
Cell Metab; 2013 Apr; 17(4):575-85. PubMed ID: 23499424
[TBL] [Abstract][Full Text] [Related]
26. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
Jia Y; Wu C; Kim J; Kim B; Lee SJ
J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
[TBL] [Abstract][Full Text] [Related]
27. [PPARβ/δ Activation prevents hypertriglyceridemia caused by a high fat diet. Involvement of AMPK and PGC-1α-Lipin1-PPARα pathway].
Barroso E; Astudillo AM; Balsinde J; Vázquez-Carrera M
Clin Investig Arterioscler; 2013; 25(2):63-73. PubMed ID: 23849213
[TBL] [Abstract][Full Text] [Related]
28. Involvement of adenosine monophosphate-activated protein kinase in the influence of timed high-fat evening diet on the hepatic clock and lipogenic gene expression in mice.
Huang Y; Zhu Z; Xie M; Xue J
Nutr Res; 2015 Sep; 35(9):792-9. PubMed ID: 26239949
[TBL] [Abstract][Full Text] [Related]
29. Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice.
Gavito AL; Bautista D; Suarez J; Badran S; Arco R; Pavón FJ; Serrano A; Rivera P; Decara J; Cuesta AL; Rodríguez-de-Fonseca F; Baixeras E
PLoS One; 2016; 11(6):e0157956. PubMed ID: 27333268
[TBL] [Abstract][Full Text] [Related]
30. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
[TBL] [Abstract][Full Text] [Related]
31. Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
Tanaka S; Yamamoto H; Nakahashi O; Kagawa T; Ishiguro M; Masuda M; Kozai M; Ikeda S; Taketani Y; Takeda E
Nutr Res; 2013 Jul; 33(7):586-93. PubMed ID: 23827134
[TBL] [Abstract][Full Text] [Related]
32. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model.
Alwayn IP; Andersson C; Lee S; Arsenault DA; Bistrian BR; Gura KM; Nose V; Zauscher B; Moses M; Puder M
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1011-9. PubMed ID: 16844679
[TBL] [Abstract][Full Text] [Related]
34. Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice.
Berriel Diaz M; Krones-Herzig A; Metzger D; Ziegler A; Vegiopoulos A; Klingenspor M; Müller-Decker K; Herzig S
Hepatology; 2008 Sep; 48(3):782-91. PubMed ID: 18712775
[TBL] [Abstract][Full Text] [Related]
35. Long-term ketogenic diet contributes to glycemic control but promotes lipid accumulation and hepatic steatosis in type 2 diabetic mice.
Zhang X; Qin J; Zhao Y; Shi J; Lan R; Gan Y; Ren H; Zhu B; Qian M; Du B
Nutr Res; 2016 Apr; 36(4):349-358. PubMed ID: 27001280
[TBL] [Abstract][Full Text] [Related]
36. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats.
Roglans N; Vilà L; Farré M; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Hepatology; 2007 Mar; 45(3):778-88. PubMed ID: 17326204
[TBL] [Abstract][Full Text] [Related]
37. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
[TBL] [Abstract][Full Text] [Related]
38. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
Garcia Caraballo SC; Comhair TM; Houten SM; Dejong CH; Lamers WH; Koehler SE
J Nutr Biochem; 2014 Dec; 25(12):1263-74. PubMed ID: 25287814
[TBL] [Abstract][Full Text] [Related]
39. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
40. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones.
Geisler CE; Renquist BJ
J Endocrinol; 2017 Jul; 234(1):R1-R21. PubMed ID: 28428362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
